Evidence map›Paper›PMID 24699521›Full record

ArticlePloS one2014

Genomic and phenotypic characterization of Vibrio cholerae non-O1 isolates from a US Gulf Coast cholera outbreak.

Bradd J Haley, Seon Young Choi, Christopher J Grim, Tiffiani J Onifade, Hediye N Cinar, Ben D Tall, Elisa Taviani, Nur A Hasan, Abdulshakur H Abdullah, Laurenda Carter and 9 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Allelic variations and gene cluster modularity act as nonlinear bottlenecks for cholera emergence.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Non-O1/Non-O139Microorganisms · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Virulence of Cholera Toxin Gene-PositiveFrontiers in microbiology · 2021
    Article
  16. Article
  17. Article
  18. Environmental and Clinical Strains ofFrontiers in microbiology · 2019
    Article
  19. Surveillance and Genomics of ToxigenicFrontiers in microbiology · 2019
    Article
  20. Environmental role of pathogenic traits inJournal of bacteriology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Bradd J HaleyMaryland Pathogen Research Institute, University of Maryland, College Park, Maryland, United States of America.
Seon Young ChoiCosmosID, College Park, Maryland, United States of America.
Christopher J GrimFood and Drug Administration, USFDA/CFSAN/DVA, Laurel, Maryland, United States of America.
Tiffiani J OnifadeFlorida Department of Health Bureau of Environmental Public Health Medicine, Tallahassee, Florida, United States of America.
Hediye N CinarFood and Drug Administration, USFDA/CFSAN/DVA, Laurel, Maryland, United States of America.
Ben D TallFood and Drug Administration, USFDA/CFSAN/DVA, Laurel, Maryland, United States of America.
Elisa TavianiMaryland Pathogen Research Institute, University of Maryland, College Park, Maryland, United States of America.
Nur A HasanMaryland Pathogen Research Institute, University of Maryland, College Park, Maryland, United States of America; CosmosID, College Park, Maryland, United States of America.
Abdulshakur H AbdullahCosmosID, College Park, Maryland, United States of America.
Laurenda CarterFood and Drug Administration, USFDA/CFSAN/DVA, Laurel, Maryland, United States of America.
Surasri N SahuFood and Drug Administration, USFDA/CFSAN/DVA, Laurel, Maryland, United States of America.
Mahendra H KotharyFood and Drug Administration, USFDA/CFSAN/DVA, Laurel, Maryland, United States of America.
Arlene ChenMaryland Pathogen Research Institute, University of Maryland, College Park, Maryland, United States of America.
Ron BakerFlorida Department of Health Bureau of Public Health Laboratories, Jacksonville, Florida, United States of America.
Richard HutchinsonFlorida Department of Health Bureau of Environmental Public Health Medicine, Tallahassee, Florida, United States of America.
Carina BlackmoreFlorida Department of Health Bureau of Environmental Public Health Medicine, Tallahassee, Florida, United States of America.
Thomas A CebulaCosmosID, College Park, Maryland, United States of America; Department of Biology, Johns Hopkins University, Baltimore, Maryland, United States of America.
Anwar HuqMaryland Pathogen Research Institute, University of Maryland, College Park, Maryland, United States of America; Maryland Institute for Applied Environmental Health, School of Public Health, University of Maryland, College Park, Maryland, United States of America.
Rita R ColwellMaryland Pathogen Research Institute, University of Maryland, College Park, Maryland, United States of America; CosmosID, College Park, Maryland, United States of America; University of Maryland Institute for Advanced Computer Studies, University of Maryland, College Park, Maryland, United States of America; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.

Funding

Effects of Climate Change on Cholera Dynamics and PredictionRC1TW008587 · FIC · TUFTS UNIVERSITY MEDFORD · PI ISLAM, SHAFIQUL · 2010 to 2010
$500k
CCR NIH HHS 1RC1TW008587-01FIC NIH HHS RC1 TW008587PHS HHS 2R01A1039129-11A2
6 · The paper itself

Abstract

Between November 2010, and May 2011, eleven cases of cholera, unrelated to a concurrent outbreak on the island of Hispaniola, were recorded, and the causative agent, Vibrio cholerae serogroup O75, was traced to oysters harvested from Apalachicola Bay, Florida. From the 11 diagnosed cases, eight isolates of V. cholerae were isolated and their genomes were sequenced. Genomic analysis demonstrated the presence of a suite of mobile elements previously shown to be involved in the disease process of cholera (ctxAB, VPI-1 and -2, and a VSP-II like variant) and a phylogenomic analysis showed the isolates to be sister taxa to toxigenic V. cholerae V51 serogroup O141, a clinical strain isolated 23 years earlier. Toxigenic V. cholerae O75 has been repeatedly isolated from clinical cases in the southeastern United States and toxigenic V. cholerae O141 isolates have been isolated globally from clinical cases over several decades. Comparative genomics, phenotypic analyses, and a Caenorhabditis elegans model of infection for the isolates were conducted. This analysis coupled with isolation data of V. cholerae O75 and O141 suggests these strains may represent an underappreciated clade of cholera-causing strains responsible for significant disease burden globally.

Indexed as

Disease OutbreaksGenomicsAnimalsBase SequenceCaenorhabditis elegansCholeraHigh-Throughput Nucleotide SequencingHumansMolecular Sequence DataPhenotypePhylogenySequence Homology, Nucleic AcidUnited StatesVibrio cholerae non-O1Virulence FactorsVirulence Factors

Identifiers

PMID24699521
PMCPMC3974666

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.